Stock LEVBIO ALPHAHELIX MOLECULAR DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

All News AlphaHelix Molecular Diagnostics AB

Equities

LEVBIO

SE0000885501

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
0.42 SEK +5.00% Intraday chart for AlphaHelix Molecular Diagnostics AB +31.25% +2.94%
04-25 Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-22 AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter Ended September 30, 2023
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
CI
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Alphahelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
CI
Xanadu Technologies AB, Tataa Biocenter AB and Active Healthtech Nordic AB acquired a 13.17% stake in AlphaHelix Molecular Diagnostics AB from Labkompaniet AB.
CI
AlphaHelix Molecular Diagnostics AB Appoints Peter Herte as Chief Executive Officer, Effective May 23, 2017
CI
AlphaHelix Molecular Diagnostics AB Auditor Raises 'Going Concern' Doubt
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LEVBIO Stock
  4. News AlphaHelix Molecular Diagnostics AB